Botox vs Dysport in Estero — A Galderma Trainer’s Honest Comparison

Patients ask me this every week: Is Dysport better than Botox?The honest answer is that I don’t pick a product per patient. I pick per zone, per goal, and sometimes per event on the calendar. Both products work. They’re not interchangeable.

I should also be straight with you up front: I’m a Galderma GAIN national trainer, which means I teach other injectors how to safely place Dysport, Restylane, and Sculptra. Galderma makes Dysport. Allergan makes Botox. I have a professional relationship with one of the two manufacturers, and you should weigh what I say with that in mind. My practice at Skinhaus Aesthetics in Estero stocks both products and I use whichever solves the problem in front of me.

The technical difference, in plain English

Both Botox (onabotulinumtoxinA, made by Allergan) and Dysport (abobotulinumtoxinA, made by Galderma) are purified type-A botulinum toxin. Injected into a targeted facial muscle, they temporarily block the nerve signal that drives that muscle’s contraction. The wrinkle on top of the muscle softens as the muscle relaxes.

Where they diverge is the protein complex that surrounds the active toxin. Botox’s complex is larger and stays closer to the injection point. Dysport’s is smaller and diffuses through tissue a bit more broadly. Neither is better in the abstract — “diffuses more” is helpful when you’re treating a broad muscle like the forehead and a problem when you’re working within millimeters of the brow.

Onset and duration — what the studies actually say

Dysport tends to onset a day or two faster. Published real-world data shows over half of Dysport patients see early movement softening within two days of treatment, versus three to five days for Botox. Both products reach their full effect at the 10–14-day mark.

Duration is essentially a tie. Both last about three to four months in most patients. Older marketing claims that one outlasts the other haven’t survived head-to-head clinical comparison. If you personally see one product wear off faster, that’s a real observation about your muscle activity — not a universal rule about the product.

Where I actually choose each one

After fourteen years of injecting, here’s the simple version of how I pick:

• Forehead. I often lean Dysport. The broader diffusion lets a smaller number of injection points cover a wide muscle (the frontalis) more smoothly. You get a more even softening with less risk of unaffected islands.
• Glabella (“11 lines”) and brow lift. Either works. I tend to favor whichever the patient has responded to before. For brow-lift technique, precision matters more than diffusion, so Botox is often my default for treatment-naive patients.
• Crow’s feet. Usually Botox. The muscle (orbicularis oculi) wraps the eye, and I don’t want any unintended diffusion into the cheek or upper-lip muscles.
• Masseter (jawline slimming, TMJ). Both work. Higher unit counts are involved, and the math sometimes favors Dysport for cost-per-effect — but only sometimes.
• Time pressure (wedding, photoshoot, event in 7–10 days). Dysport edges out by a day or two of onset. Not a magic trick, but worth knowing.

The unit-conversion myth

The most confusing thing for patients comparing prices is units. A unit of Dysport is not equivalent to a unit of Botox. The clinically-validated conversion ratio is approximately 2.5 to 1 — that is, 50 units of Dysport produce roughly the same effect as 20 units of Botox. This ratio comes from peer-reviewed double-blind comparison studies for both glabellar lines and cervical dystonia.

Why this matters at billing time: a quoted “per-unit” price for Dysport will always look much lower than for Botox, because you’re using 2.5× more units to do the same job. Compare total session cost, not per-unit price. Any honest practice will quote you both ways on request.

Contraindications and the conservative reality

Both products share the same safety profile, documented on the current Botox FDA label. They’re both off the table during pregnancy and breastfeeding (insufficient safety data, not proven harm — but the medical bar for cosmetic procedures during pregnancy is “don’t”). Patients with neuromuscular conditions such as myasthenia gravis, ALS, or Lambert-Eaton syndrome should not receive either. Recent courses of aminoglycoside antibiotics require a short delay.

And then the thing nobody talks about: even with the right product in the right zone, dosing matters more than the brand. A heavy hand with Dysport will give you a frozen forehead just as fast as a heavy hand with Botox. The conservative dosing I teach in GAIN — start subtle, re-evaluate at the two-week follow-up, add more if the patient wants it — is the actual answer to “will I look frozen.” The product is secondary.

A short field guide for Estero and Naples patients

If you’re local to Estero, Naples, Bonita Springs, or Fort Myers and you’re deciding where to start:

• You don’t need to pick the product before you arrive. That’s what the consultation is for.
• If you’ve had Botox before and liked it, there’s no reason to switch unless something specific bothered you (slow onset, short duration relative to other patients you compare notes with).
• If you’ve never had either, we’ll likely start with the one whose properties fit your treatment zones — and re-evaluate at your two-week follow-up.
• Anyone who tries to upsell you on a “better” product before reviewing your face is selling a product, not delivering care. That’s true at Skinhaus and everywhere else.

If you want to talk through what makes sense for you, you can request a consultation or read more about the full injectables menu at Skinhaus. I’ll meet you where you are.